Pharmavrai SRL
Pharmavrai reported total assets of 880,268 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of Pharmavrai shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +21 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmavrai's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 85,639 € | ||||
| Equity | 306,070 € | ||||
| Cash | 169,817 € | ||||
| EBITDA | 212,517 € | ||||
| Total assets | 880,268 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 29 May 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
Pharmavrai's financial analysis
- Solvency34.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmavrai
Pharmavrai's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0552.535.853
- VAT number
- BE0552535853
- Peppol
- Registered · 0208:0552535853 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 May 2014
- Registered office
- 4500 Huy
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmavrai (SRL) has been based in Huy since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 85,639 € and equity of 306,070 €; its revenue is not published. Its solvency stands at 34.8%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmavrai
Companies in the same business, of comparable size and area, outside its group.
- ERC Pharma Alpha Retail sale of pharmaceutical products Jette · balance sheet 880,509 €
- Apotheek De Pot Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 880,893 €
- Apoteek Dreezen Retail sale of pharmaceutical products Hasselt · balance sheet 882,214 €
- Pharmacie des Citronniers Retail sale of pharmaceutical products Brussels · balance sheet 882,658 €
- Cobra Apotheek Rosselaar Retail sale of pharmaceutical products Mol · balance sheet 884,462 €
- Phinn Retail sale of pharmaceutical products Buggenhout · balance sheet 885,031 €
- Lo Farma Retail sale of pharmaceutical products Lochristi · balance sheet 875,320 €
- Pharmazinnes Retail sale of pharmaceutical products Namur · balance sheet 875,224 €
Frequently asked questions about Pharmavrai
What is the revenue of Pharmavrai?
Pharmavrai files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmavrai?
In Belgium, the VAT number is the company number prefixed with BE: BE0552535853 for Pharmavrai, if the company is VAT-registered. Its company number (CBE) is 0552.535.853.
Where is the registered office of Pharmavrai?
According to the CBE register, the registered office of Pharmavrai is in 4500 Huy.
What is the equity of Pharmavrai?
At the close of the 2025 financial year, the equity of Pharmavrai amounts to 306,070 €, a solvency of 34.8% of total assets.
Who manages Pharmavrai?
The register lists 2 active mandates at Pharmavrai. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmavrai
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →